Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca won't file cancer drug submission
Marketwatch
Friday, May 28, 2010 - 8:41am
tags:
Recentin, colorectal cancer, AstraZeneca
Bioethics Expert To FDA: Scrap Glaxo’s Avandia Trial
Pharmalot
Thursday, May 27, 2010 - 8:17pm
tags:
GSK, lawsuits, Avandia, FDA, diabetes, ethics, TIDE
A Phantom Returns to Haunt J&J: Secret Motrin Pullback Is a Lesson in What Not to Do
BNET Pharma
Thursday, May 27, 2010 - 8:14pm
tags:
JNJ, recalls, Motrin, FDA
Good News for Novo Nordisk
Yahoo/Zacks.com
Thursday, May 27, 2010 - 8:13pm
tags:
Novo Nordisk, diabetes, Eli Lilly, Pfizer, Victoza, Canada
Inspra Study Won't Help Pfizer
Forbes
Thursday, May 27, 2010 - 6:29pm
tags:
Inspra, Pfizer, heart failure
Big Pharma Eyes India
Seeking Alpha
Thursday, May 27, 2010 - 6:26pm
tags:
India, Piramal Healthcare, Abbott Laboratories, M&A, Big Pharma, GSK, Dr Reddy's, Ranbaxy, Daiichi Sankyo
Update on Xenoport's Horizant
Yahoo/Zacks.com
Thursday, May 27, 2010 - 6:24pm
tags:
Horizant, XenoPort
What Investors Think About China Pharma Holdings
Motley Fool
Thursday, May 27, 2010 - 6:23pm
tags:
China Pharma Holdings, investors
Why Glaxo Will Be Furious At FDA's New Side Effect Warning for Its Diet Drug Alli
BNET Pharma
Thursday, May 27, 2010 - 10:32am
tags:
Alli, GSK, warnings, diet drugs
Anadys mulls strategic options on hepatitis C drug
Yahoo/AP
Thursday, May 27, 2010 - 10:29am
tags:
Anadys, hepatitis C
J&J Unit Could Face Criminal Action
TheStreet.com
Thursday, May 27, 2010 - 10:28am
tags:
JNJ, FDA
Healthcare Reform May Provide an Opportunity for Teva
Seeking Alpha
Thursday, May 27, 2010 - 10:27am
tags:
healthcare reform, Teva Pharmaceuticals, Rituxan, biosimilars
Valeant completes $318 M purchase of Aton Pharma
Yahoo/AP
Thursday, May 27, 2010 - 10:25am
tags:
Aton Pharma, M&A, Valeant Pharmaceuticals
Celgene says Teva division Barr withdrew cancer drug application, Celgene dropped patent suit
Yahoo/AP
Thursday, May 27, 2010 - 10:07am
tags:
Celgene, Teva Pharmaceuticals, Barr Laboratories, lawsuits, Thalomid, generics
ASCO - A Big Deal For Biotechs
Investopedia
Thursday, May 27, 2010 - 10:05am
tags:
ASCO, biotech, Abbott Laboratories, Ariad Pharmaceuticals, Arqule, Bristol-Myers Squibb, Keryx, Nektar, Merck, Vanda, Aeterna Zentaris
FDA Inspection Report Cited 20 Violations for J&J
WSJ Online
Thursday, May 27, 2010 - 10:03am
tags:
FDA, drug manufacturing, JNJ
Sanofi Sees ‘Significant Interest’ in Animal Health
Bloomberg Businessweek
Thursday, May 27, 2010 - 8:21am
tags:
animal health, Sanofi, Merck, Pfizer, Bayer, Boehringer Ingelheim, Novartis
Delivering on Comparative Value Expectations for the Healthcare Market
Pharmareform
Thursday, May 27, 2010 - 8:19am
tags:
comparative effectiveness, healthcare reform
4 Small Cap Biotechs to Keep an Eye On
Seeking Alpha
Thursday, May 27, 2010 - 8:01am
tags:
biotech, Affymax, AspenBio, Questcor Pharmaceuticals, Ardea
Sanofi Says Cabazitaxel Improved Prostate Cancer Survival by 28%
Bloomberg
Thursday, May 27, 2010 - 7:48am
tags:
prostate cancer, cabazitaxel, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.